Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Psychosocial Treatment of Depression in Parkinson's Disease

15. november 2012 opdateret af: Amy Farabaugh, PhD
The purpose of the study is to examine the effects of a form of talk therapy called cognitive behavior therapy (CBT) in the treatment of major depression in individuals with Parkinson's disease (PD).

Studieoversigt

Detaljeret beskrivelse

CBT is a specific type of treatment that has been shown to be as helpful in treating depression as medications for depression. CBT focuses on thoughts, feelings, and behaviors. It focuses on the here and now, rather than the past. CBT offers concrete strategies and skills for coping with depression, PD, and other life problems. Previous research leads us to believe that this type of therapy may help people with PD cope with their depression.

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

80

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Massachusetts
      • Boston, Massachusetts, Forenede Stater, 02114
        • Massachusetts General Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

40 år til 80 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

In addition to the DSM-IV diagnostic criteria for major depressive disorder, the following conditions must be met for patient eligibility:

  • Written informed consent.
  • Subjects with a primary diagnosis of PD who also currently meet DSM-IV criteria for MDD
  • Subjects must be stable on their anti-Parkinson treatment, as defined by no medication changes over the past 6 weeks
  • Subjects may be taking an antidepressant as long as they have had a stable dose for up to 6 weeks and do not alter the dosage during the course of the study
  • Men or women 40-80 years of age
  • HAMD-17 scores > 14 at screen visit
  • Score of 25 or greater on the Mini-Mental Status Examination
  • Willing to come to MGH for screening and study participation

Exclusion Criteria:

Patients meeting any of the following criteria are to be excluded from the study:

  • Subjects who, in the investigator's judgment, pose a current, serious suicidal or homicidal risk
  • Patients who would not be appropriate for a delayed CBT control due to the severity of their depression based on clinical judgment as well as HAMD-17 scores > 28
  • The following DSM-IV diagnoses: 1) substance use disorders, including alcohol dependence, active within the last 3 months; 2) schizophrenia; 3) delusional disorder; 4) psychotic disorders not elsewhere classified; 5) bipolar disorder; 6) MDD with psychotic features
  • Subjects who meet DSM-IV criteria for dementia
  • Severe, unstable concurrent medical conditions (determined by his/her physician) that are likely to require hospitalization within six months from study entry (e.g., a patient with severe congestive heart failure who has a history of recent hospital admissions)
  • Subjects may not be receiving a psychosocial intervention that is specific for depression; psychosocial interventions not specific for depression (e.g., couples counseling) and established for three or more months before screen visit are allowed

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: 1
Patients randomized to the immediate arm will be given 12 weeks of CBT starting one week after randomization
12 weeks of Cognitive Behavioral Therapy designed for adults with Parkinson's Disease and comorbid Depression
Andre navne:
  • CBT
  • Psykosocial intervention
  • Terapi
  • Kognitiv terapi
Aktiv komparator: 2
Patients in the delayed arm will receive 12 weeks of CBT, starting 12 weeks after randomization.
12 weeks of Cognitive Behavioral Therapy designed for adults with Parkinson's Disease and comorbid Depression
Andre navne:
  • CBT
  • Psykosocial intervention
  • Terapi
  • Kognitiv terapi

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Response according to the Hamilton Rating Scale for Depression, 17 items (HAM-D 17).
Tidsramme: screen, week 4, week 8, week 12; if applicable, week 16, week 20, week 24
screen, week 4, week 8, week 12; if applicable, week 16, week 20, week 24

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Amy Farabaugh, PhD, Massachusetts General Hospital

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. april 2007

Primær færdiggørelse (Forventet)

1. april 2013

Studieafslutning (Forventet)

1. april 2013

Datoer for studieregistrering

Først indsendt

27. februar 2009

Først indsendt, der opfyldte QC-kriterier

27. februar 2009

Først opslået (Skøn)

2. marts 2009

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

16. november 2012

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

15. november 2012

Sidst verificeret

1. november 2012

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner